Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Katherine Sanchez
  • Shu-Ching Chang, Medical Data Research Center, Providence Health & Services, Portland, OR, USA
  • Isaac Kim
  • Maritza Martel
  • Yaping Wu, Pathology, Providence Portland Medical Center
  • William L Redmond, Earle A Chiles Research Institute
  • Zhaoyu Sun
  • Dottie Waddell
  • Deborah R Laxague
  • Brady Bernard
  • Monil Shah
  • Walter Urba, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, 97213, USA.
  • David B Page
Link
Document Type
Article
Publication Date
5-25-2020
Disciplines
Clinical Institute
Cancer
Specialty
Oncology
Specialty
Earle A. Chiles Research Institute
Citation Information
Katherine Sanchez, Shu-Ching Chang, Isaac Kim, Maritza Martel, et al.. "Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)
Available at: http://works.bepress.com/walter-urba/290/